Current Edition

copycat

Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024

After Teva Pharmaceutical snagged the OK to launch its Victoza generic in 2023, another copycat has secured a launch timeline for its generic to Novo …

Continue Reading →